CJC-1295 and Ipamorelin: The Growth Hormone Peptide Stack Explained

Among the many peptide protocols we use at MedTech Management, the CJC-1295 and Ipamorelin combination is consistently one of the most requested. Patients come to us having heard about it from friends, podcasts, or online communities — and for good reason. When used correctly and under medical supervision, this stack delivers meaningful results. Here is what you need to know.

What Is CJC-1295?

CJC-1295 is a synthetic peptide that stimulates the release of growth hormone from the pituitary gland. Unlike synthetic human growth hormone (HGH) which replaces your body’s own production, CJC-1295 works with your body — triggering your pituitary to release more of its own growth hormone naturally. It has a long half-life, meaning it stays active in the body for days rather than hours.

What Is Ipamorelin?

Ipamorelin is a growth hormone secretagogue — it mimics the hormone ghrelin and binds to receptors in the pituitary and hypothalamus to stimulate growth hormone release. It is considered one of the cleanest and most selective GH releasers available because it does not significantly raise cortisol or prolactin levels the way other secretagogues can.

Why Combine Them?

CJC-1295 and Ipamorelin work through two different mechanisms to stimulate growth hormone release — and when combined, their effects are synergistic. The result is a more pronounced and sustained elevation of growth hormone than either peptide produces alone. Think of it as hitting two different switches that both turn on the same light.

What Are the Benefits?

Patients on a CJC-1295 and Ipamorelin protocol commonly report:

• Improved sleep quality — particularly deeper, more restorative sleep
• Faster recovery from workouts and physical activity
• Improved body composition — more muscle, less body fat over time
• Increased energy and vitality
• Improved skin quality and reduced signs of aging
• Enhanced mental clarity

Most patients begin noticing improvements in sleep within the first one to two weeks. Body composition changes typically become noticeable after 6 to 8 weeks of consistent use.

Who Is a Good Candidate?

This protocol is commonly used by men and women over 35 who are experiencing the effects of declining growth hormone levels — reduced energy, slower recovery, increasing body fat, and poor sleep. It is also popular with athletes looking to optimize performance and recovery without the risks associated with synthetic HGH.

What Does a Protocol Look Like?

CJC-1295 and Ipamorelin are typically administered as subcutaneous injections 5 days per week, most commonly before bed to align with the body’s natural overnight growth hormone pulse. Dosing is individualized based on your goals, body weight, and health history. Protocols are typically run for 3 to 6 months with periodic breaks.

Get Started with a Free Consultation

If you are curious whether CJC-1295 and Ipamorelin is right for you, the next step is a conversation with our clinical team. We review your health history, discuss your goals, and build a protocol designed for your body. Text us at (412) 207-3770 or visit medtechmanagement.com to schedule your free consultation. We serve patients nationwide via telehealth.